Prevalence of monoclonal gammopathy of undetermined significance (MGUS) at HIV diagnosis in individuals 18-40 years old: a possible HIV indicator condition.
作者信息
Bibas Michele, Pittalis Silvia, Orchi Nicoletta, De Carli Gabriella, Agrati Chiara, Girardi Enrico, Antinori Andrea, Puro Vincenzo, Ippolito Giuseppe
机构信息
National Institute for Infectious Diseases "Lazzaro Spallanzani", Rome, Italy.
出版信息
Blood Cancer J. 2021 May 16;11(5):91. doi: 10.1038/s41408-021-00489-1.
Abstract
摘要
相似文献
1
Prevalence of monoclonal gammopathy of undetermined significance (MGUS) at HIV diagnosis in individuals 18-40 years old: a possible HIV indicator condition.18至40岁个体在HIV诊断时意义未明的单克隆丙种球蛋白病（MGUS）的患病率：一种可能的HIV指示性病症。
Blood Cancer J. 2021 May 16;11(5):91. doi: 10.1038/s41408-021-00489-1.
2
Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).意义未明的单克隆丙种球蛋白病（MGUS）意义未明的单克隆丙种球蛋白病（MGUS）。
Klin Onkol. 2018 Summer;31(4):270-276. doi: 10.14735/amko2018270.
3
Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.亚洲地区意义未明的单克隆丙种球蛋白血症的流行情况：来自长崎原子弹幸存者的观点。
Clin Lymphoma Myeloma Leuk. 2014 Feb;14(1):18-20. doi: 10.1016/j.clml.2013.12.010. Epub 2013 Dec 19.
4
Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30 years among atomic bomb survivors in Hiroshima.30 年来，在广岛原子弹幸存者中筛查 M 蛋白血症（包括意义未明的单克隆丙种球蛋白血症和多发性骨髓瘤）。
Int J Hematol. 2021 Apr;113(4):576-585. doi: 10.1007/s12185-020-03045-y. Epub 2021 Jan 3.
5
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS).意义未明单克隆丙种球蛋白病（MGUS）年轻患者的预后。
Blood Cancer J. 2021 Feb 1;11(2):26. doi: 10.1038/s41408-021-00406-6.
6
Pathogenesis of monoclonal gammopathy of undetermined significance and progression to multiple myeloma.意义未明的单克隆丙种球蛋白血症的发病机制及进展为多发性骨髓瘤。
Semin Hematol. 2011 Jan;48(1):4-12. doi: 10.1053/j.seminhematol.2010.11.003.
7
Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey.10-49 岁人群中骨髓瘤前体状态意义未明的单克隆γ球蛋白病流行率：来自国家健康和营养检查调查的一项基于人群的研究。
Blood Cancer J. 2017 Oct 20;7(10):e618. doi: 10.1038/bcj.2017.97.
8
[Monoclonal gammopathy of undetermined significance].意义未明的单克隆丙种球蛋白病
Ann Med Interne (Paris). 2002 Nov;153(7):459-66.
9
[Monoclonal gammopathy of undetermined significance (MGUS): interpretative shades of analysis and sometimes serious clinical consequences].意义未明的单克隆丙种球蛋白病（MGUS）：分析的解读细微差别及有时严重的临床后果
Ann Biol Clin (Paris). 2019 Jun 1;77(3):245-254. doi: 10.1684/abc.2019.1440.
10
Untangling fracture risk in monoclonal gammopathy of undetermined significance: A population-based cohort study.未确定意义的单克隆丙种球蛋白血症中的骨折风险解析：一项基于人群的队列研究。
Eur J Haematol. 2021 Jul;107(1):137-144. doi: 10.1111/ejh.13633. Epub 2021 Apr 28.
引用本文的文献
1
Chronic Viral Infections and Al Amyloidosis: An Uncommon Association.慢性病毒感染与阿尔茨海默病淀粉样变性：一种罕见的关联。
Clin Case Rep. 2025 Apr 2;13(4):e9616. doi: 10.1002/ccr3.9616. eCollection 2025 Apr.
本文引用的文献
1
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS).意义未明单克隆丙种球蛋白病（MGUS）年轻患者的预后。
Blood Cancer J. 2021 Feb 1;11(2):26. doi: 10.1038/s41408-021-00406-6.
2
Risk factors for monoclonal gammopathy of undetermined significance: a systematic review.不明意义单克隆丙种球蛋白血症的危险因素：系统综述。
Ann Hematol. 2021 Apr;100(4):855-863. doi: 10.1007/s00277-021-04400-7. Epub 2021 Jan 8.
3
Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study - 2012 - 2015.提高在欧洲使用指征性疾病引导的 HIV 检测的证据：HIDES II 研究的结果-2012-2015 年。
PLoS One. 2019 Aug 13;14(8):e0220108. doi: 10.1371/journal.pone.0220108. eCollection 2019.
4
Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey.10-49 岁人群中骨髓瘤前体状态意义未明的单克隆γ球蛋白病流行率：来自国家健康和营养检查调查的一项基于人群的研究。
Blood Cancer J. 2017 Oct 20;7(10):e618. doi: 10.1038/bcj.2017.97.
5
Prevalence of monoclonal gammopathy in HIV patients in 2014.2014年HIV患者中单克隆丙种球蛋白病的患病率。
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19649. doi: 10.7448/IAS.17.4.19649. eCollection 2014.
6
Pivotal role of HIV and EBV replication in the long-term persistence of monoclonal gammopathy in patients on antiretroviral therapy.HIV 和 EBV 复制在抗逆转录病毒治疗患者的单克隆丙种球蛋白血症的长期持续存在中起关键作用。
Blood. 2013 Oct 24;122(17):3030-3. doi: 10.1182/blood-2012-12-470393. Epub 2013 Aug 12.
7
Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study).指标性疾病导向检测用于 HIV 的可行性和有效性：来自 HIDES I（全欧 HIV 指标性疾病研究）的结果。
PLoS One. 2013;8(1):e52845. doi: 10.1371/journal.pone.0052845. Epub 2013 Jan 15.
8
Prevalence of monoclonal gammopathy of undetermined significance.意义未明的单克隆丙种球蛋白病的患病率。
N Engl J Med. 2006 Mar 30;354(13):1362-9. doi: 10.1056/NEJMoa054494.
Zotero 插件